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Objective: Injection drug users are often excluded from hepatitis C virus (HCV)
treatment. This study compares sustained virological response, adherence, and
quality of life in patients with or without a history of illicit drug use in routine clinical
practice.Methods: This is a post-hoc analysis of a prospective, observational study
conducted in 1860 patients who received peginterferon α-2b/ribavirin combination
therapy. Nondrug users (NDUs) were defined as patients without a history of drug
addiction; former drug users (FDUs) as patients who had stopped using illicit drugs
or opioid maintenance therapy and active drug users (ADUs) as patients using illicit
drugs or on opioid maintenance therapy. Virological response, adherence, and the
health-related quality of life were assessed by the measure of HCV RNA in the
serum, self-report and 36-item short-form health survey Questionnaire, respectively.
Results: The analyzed population included 1038 (56%) NDUs, 578 (31%) FDUs, and
244 (13%) ADUs. About 85% of ADUs were on opioid maintenance therapy and 25%
used illicit drugs. Although ADUs had a more chaotic lifestyle and more psychiatric
disorders, sustained virological response of ADUs (58%) did not differ from that of
NDUs (49%) and FDUs (51%) (P=0.133). Adherence rates were 39% in NDUs and
FDUs, and 37% in ADUs (P=0.883). Health-related quality of life was improved in the
three groups after the end of treatment. Conclusion: Our study suggests that HCV
therapy in ADUs on opioid maintenance therapy is as effective as in other HCV
patients. The effectiveness of HCV therapy in illicit drug users needs to be evaluated
in further studies.
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